Alliance Pharma plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 180.68 million compared to GBP 167.42 million a year ago. Sales was GBP 180.68 million compared to GBP 167.42 million a year ago.

Net loss was GBP 33.14 million compared to GBP 21.21 million a year ago. Net loss was GBP 33.14 million compared to GBP 21.21 million a year ago. Basic loss per share from continuing operations was GBP 0.0613 compared to GBP 0.0393 a year ago.

Basic loss per share from continuing operations was GBP 0.0613 compared to GBP 0.0393 a year ago. Diluted loss per share from continuing operations was GBP 0.0613 compared to GBP 0.0393 a year ago. Diluted loss per share from continuing operations was GBP 0.0613 compared to GBP 0.0393 a year ago.